Volitionrx (VNRX) Revenue (2012 - 2025)
Volitionrx (VNRX) posted Revenue of $362379.0 for Q4 2025, down 42.23% on a QoQ basis from $627277.0 in Q3 2025, and up 203.93% year-over-year from $119232.0 in Q4 2024.
Volitionrx (VNRX) Revenue (2012 - 2025) Analysis & Trends
Volitionrx's Revenue history runs 8 years deep, the most recent figure standing at $362379.0 for Q4 2025.
- Quarterly Revenue rose 203.93% year-over-year to $362379.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (up 52.11% YoY) and the FY2025 annual result came in at $1.3 million, up 26.98% from the prior year.
- Revenue was $362379.0 for Q4 2025 at Volitionrx, down from $627277.0 in the prior quarter.
- Across five years, Revenue topped out at $627277.0 in Q3 2025 and bottomed at -$100674.0 in Q4 2022.
- A 5-year average of $158661.7 and a median of $123377.5 in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2021 — Revenue jumped 4593.01% — and 2022, when it sank 806.98%.
- Volitionrx's Revenue stood at $14240.0 in 2021, then sank by 806.98% to -$100674.0 in 2022, then soared by 166.68% to $67128.0 in 2023, then soared by 77.62% to $119232.0 in 2024, then jumped by 203.93% to $362379.0 in 2025.
- Business Quant data shows VNRX's Revenue at $362379.0 in Q4 2025, $627277.0 in Q3 2025, and $244910.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.19 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.57 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | 362,379.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 362,379.00 |
| Sep 30, 2025 | 627,277.00 |
| Jun 30, 2025 | 244,910.00 |
| Mar 31, 2025 | 246,385.00 |
| Dec 31, 2024 | 119,232.00 |
| Sep 30, 2024 | 406,088.00 |
| Jun 30, 2024 | 279,707.00 |
| Mar 31, 2024 | 168,597.00 |
| Dec 31, 2023 | 67,128.00 |
| Sep 30, 2023 | 127,523.00 |
| Jun 30, 2023 | 216,310.00 |
| Mar 31, 2023 | 144,452.00 |
| Dec 31, 2022 | -100,674.00 |
| Sep 30, 2022 | 19,922.00 |
| Jun 30, 2022 | 39,752.00 |
| Mar 31, 2022 | 114,211.00 |
| Dec 31, 2021 | 14,240.00 |
| Sep 30, 2021 | 25,483.00 |
| Jun 30, 2021 | 24,782.00 |
| Mar 31, 2021 | 25,530.00 |